Turtle Creek Wealth Advisors’s Orthofix Medical OFIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-35,135
Closed -$533K 505
2025
Q4
$533K Hold
35,135
0.04% 231
2025
Q3
$514K Hold
35,135
0.05% 208
2025
Q2
$392K Hold
35,135
0.05% 193
2025
Q1
$573K Hold
35,135
0.09% 102
2024
Q4
$613K Hold
35,135
0.14% 62
2024
Q3
$549K Hold
35,135
0.11% 96
2024
Q2
$466K Hold
35,135
0.11% 94
2024
Q1
$510K Hold
35,135
0.13% 89
2023
Q4
$474K Buy
+35,135
New +$413K 0.14% 91

Other funds holding OFIX

Turtle Creek Wealth Advisors's OFIX Position: Q1 2026 in Review

Turtle Creek Wealth Advisors sold out of Orthofix Medical (OFIX) in Q1 2026, closing a stake of 35,135 shares — an estimated $533K sold.

Turtle Creek Wealth Advisors first reported a position in OFIX in Q4 2023 and held it in 9 quarters. The position peaked at $613K in Q4 2024. 147 funds tracked by Wall St. Rank hold OFIX as of Q1 2026.

  • Turtle Creek Wealth Advisors reported no remaining Orthofix Medical position as of Q1 2026 after selling out during the quarter.
  • Turtle Creek Wealth Advisors sold 35,135 Orthofix Medical shares in Q1 2026, an estimated $533K.
  • Turtle Creek Wealth Advisors first reported a position in Orthofix Medical in Q4 2023 and held it in 9 quarters.
  • Turtle Creek Wealth Advisors's Orthofix Medical position peaked at $613K in Q4 2024.
  • 147 funds tracked by Wall St. Rank held Orthofix Medical as of Q1 2026.

Based on Turtle Creek Wealth Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.